E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression
An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic…
Lilly invests in epigenetic reprogramming biotech
NewLimit adds $45m in new funding at a $1.6bn valuation following preclinical progress that brings clinical trials closer…
Scientists question the safety and efficacy of the diet for metabolic health
A study published in Science Advances by University of Utah Health researchers sheds light on the long-term effects…
MRI age clocks reveal how each organ ages differently and predict who develops disease or lives longer
By decoding age gaps across the brain, heart, liver, and more, scientists show that no two organs grow…
Nanoparticles offer new hope for treating alcohol-related liver disease
Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease…
Ganoderma lucidum protects against liver damage from high-fat diets
Background and objectives A long-term high-fat diet (HFD) exerts lipotoxic effects on multiple organs, particularly the liver, leading…
Study links gut dysbiosis with severe steatosis in MASLD
A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a…
New composite sponge offers rapid and safe control of surgical hemorrhage
Uncontrolled bleeding during surgery remains one of the deadliest medical emergencies. Injuries to internal organs such as the…
Using a lab-designed protein to regulate blood glucose levels
Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels…
Japan’s registry transforms outcomes for infants with biliary atresia
Biliary atresia (BA) is the leading cause of liver failure in infants, marked by progressive destruction of the…
Antihypertensive and lipid-lowering drugs show efficacy against steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one third…
Supplements that aren’t a magic fix, but you are taking them anyway
The supplement sales have surpassed $150 billion in the United States in 2023. There are over 80,000 unique…